Staff Reports Apr 29, 2021 ALBANY, Ga. â Following a thorough safety review, the U.S. Food and Drug Administration, the CDC, and the Advisory Committee on Immunization Practices have determined that the recommended pause regarding the use of the Johnson & Johnson COVID vaccine in the U.S. should be lifted. As of April 28, the Southwest Public Health District resumed the use of the Johnson & Johnson vaccine for Georgians aged 18 and older, said Dr. Charles Ruis, health director, Southwest Public Health District 8-2. âBecause our supply of that vaccine tends to be lower than our Moderna inventory, it is reserved for those individuals best served by a single dose option,â he said, such as those vaccinated on site at schools and businesses as well as those who are homebound.